Identify the key amino acid of BAFF binding with TACI

Cellular Immunology

Volumn 284, Issue 1-2, 2013, Pages 84-90

  Wang, Renxi ^a   Wang, Ru ^b   Ma, Ning ^a,c   Guo, Yueling ^d   Xiao, He ^a   Chen, Guojiang ^a   Han, Gencheng ^a   Hou, Chunmei ^a   Shen, Beifen ^a   Feng, Jiannan ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b The 305 Hospital of the People's Liberation Army   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

BAFF; Key amino acid; Molecular modeling; TACI

Indexed keywords

ALANINE; AMINO ACID; B CELL ACTIVATING FACTOR; GLUTAMIC ACID; HISTONE; LYSINE; METHIONINE; MONOMER; PROLINE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL SURVIVAL; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA SEQUENCE; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SPLEEN CELL;

BAFF; KEY AMINO ACID; MOLECULAR MODELING; TACI;

ANIMALS; B-CELL ACTIVATING FACTOR; HUMANS; KINETICS; METHIONINE; MICE; MICE, INBRED C57BL; MOLECULAR DOCKING SIMULATION; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

EID: 84882769645     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.06.003     Document Type: Article

References (30)

1. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D., Li Y., Galperina O., Giri J., Roschke V., Nardelli B., Carrell J., Sosnovtseva S., Greenfield W., Ruben S.M., Olsen H.S., Fikes J., Hilbert D.M. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999, 286:260-263.
2. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R.H., Browning J.L., Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 1999, 189:1747-1756.
3. Mackay F., Browning J.L. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2002, 2:465-475.
4. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF developed lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999, 190:1697-1710.
5. Mackay F., Schneider P. Cracking the BAFF code. Nat. Rev. Immunol. 2009, 9:491-502.
6. Yang M., Sun L., Wang S., Ko K.H., Xu H., Zheng B.J., Cao X., Lu L. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 2010, 184:3321-3325.
7. Lee J.J., Rauter I., Garibyan L., Ozcan E., Sannikova T., Dillon S.R., Cruz A.C., Siegel R.M., Bram R., Jabara H., Geha R.S. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood 2009, 114:2254-2262.
8. Wood P.M. Primary antibody deficiency syndromes. Curr. Opin. Hematol. 2010, 17:356-361.
9. He B., Santamaria R., Xu W., Cols M., Chen K., Puga I., Shan M., Xiong H., Bussel J.B., Chiu A., Puel A., Reichenbach J., Marodi L., Döffinger R., Vasconcelos J., Issekutz A., Krause J., Davies G., Li X., Grimbacher B., Plebani A., Meffre E., Picard C., Cunningham-Rundles C., Casanova J.L., Cerutti A. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat. Immunol. 2010, 11:836-845.
10. Cerutti A., Chen K. Role of BAFF and APRIL in antibody production and diversification. BLyS Ligands and Receptors 2010, 65-92. Human Press, Pennsylvania. M.P. Cancro (Ed.).
11. Mackay F., Schneider P. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev. 2008, 19:263-276.
12. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C., Moore M., Littau A., Grossman A., Haugen H., Foley K., Blumberg H., Harrison K., Kindsvogel W., Clegg C.H. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000, 404:995-999.
13. Bossen C., Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 2006, 18:263-275.
14. Hymowitz S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J., Shriver S.K., Gordon N.C., Pan B., Skelton N.J., Kelley R.F., Starovasnik M.A. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J. Biol. Chem. 2005, 280:7218-7227.
15. Xia J.F., Wang S.L., Lei Y.K. Computational methods for the prediction of protein-protein interactions. Protein Pept. Lett. 2010, 17:1069-1078.
16. Hue M., Riffle M., Vert J.P., Noble W.S. Large-scale prediction of protein-protein interactions from structures. BMC Bioinf. 2010, 11:144.
17. Navarra S.V., Guzmán R.M., Gallacher A.E., Hall S., Levy R.A., Jimenez R.E., Li E.K., Thomas M., Kim H.Y., León M.G., Tanasescu C., Nasonov E., Lan J.L., Pineda L., Zhong Z.J., Freimuth W., Petri M.A. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 2011, 377:721-731.
18. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcón G.S., Fessler B.J., Bastian H., Kimberly R.P., Zhou T. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 2001, 166:6-10.
19. Cheema G.S., Roschke V., Hilbert D.M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001, 44:1313-1319.
20. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., Tschopp J., Cachero T.G., Batten M., Wheway J., Mauri D., Cavill D., Gordon T.P., Mackay C.R., Mackay F. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 2002, 109:59-68.
21. Ramanujam M., Davidson A. BAFF blockade for systemic lupus erythematosus - will the promise be fulfilled?. Immunol. Rev. 2008, 223:156-174.
22. Hymowita S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J., Shriver S.K., Gordon N.C., Pan B., Skelton N.J., Kelley R.F., Starovasnik M.A. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J. Biol. Chem. 2005, 280:7218-7227.
23. Janin J., Bahadur R.P., Chakrabarti P. Protein-protein interaction and quaternary structure. Q. Rev. Biophys. 2008, 41:133-180.
24. Rain J.C., Selig L., Reuse H.D., Battaglia V., Reverdy C., Simon S., Lenzen G., Petel F., Wojcik J., Schächter V., Chemama Y., Labigne A., Legrain P. The protein-protein interaction map of helicobacter pylori. Nature 2001, 409:211-215.
25. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., Timm J., Mintzlaff S., Abraham C., Bock N., Kietzmann S., Goedde A., Toksöz E., Droege A., Krobitsch S., Korn B., Birchmeier W., Lehrach H., Wanker E.E. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968.
26. Ivica R., Olivier L. Character and evolution of protein-protein interfaces. Phys. Biol. 2005, 2:S36.
27. Florencio P., Manuela H.C., Gabriele A. Valencia A, correlated mutations contain information about protein-protein interaction. J. Mol. Biol. 1997, 271:511-523.
28. Castigli E., Wilson S.A., Scott S., Dedeoglu F., Xu S., Lam K.P., Bram R.J., Jabara H., Geha R.S. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 2005, 201:35-39.
29. Sun X.H., Kincade P.W. Gatekeeper mechanisms for immature B cells. Nat. Immunol. 2002, 3:898-899.
30. Melchers F. Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease. Ann. Rheum. Dis. 2003, 62(Suppl. 2):ii25-ii27.